Press release

  1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | From 8 Next page Last page Next page

Title Date
SEPPIC Opens Doors of New Production Unit, 1st Sterile High-Volume Packaging Line for Vaccine Adjuvants and Injectables
Today SEPPIC, a leader in the global market for vaccine adjuvants, is launching operations at its new production unit for vaccine adjuvants and injectables in Castres, France. The ultramodern facility puts SEPPIC at the cutting edge of technology. It is now the only company producing large quantities of sterile pharmaceutical excipients¹ and packaging them in pouches with volumes as great as 200 L. SEPPIC will eventually be offering sizes up to 1,000 L.

October 17, 2014
SEPPIC presents Sea Shine, its new active ingredient – by BiotechMarine
Sea Shine, sourced in the pure waters of the Brehat archipelago - Brittany, France, is the fruit of a comprehensive and innovative research on the mechanisms involved in skin pigmentation.

March 28, 2014
SEPPIC launches in the cosmetic hair-care market
SEPPIC is already recognized for its expertise in active ingredients, thickening products and emulsifiers for skincare, and is now launching into the haircare field with high-performance ingredients.

March 14, 2014
SEPPIC obtains EXCiPACT™ Certification
In December 2013, SEPPIC became the first French company and only the fourth company worldwide to obtain EXCiPACT™ certification.

March 5, 2014
Launch of “Algraal” Project, led by SEPPIC
On January 30, 2014, SEPPIC and its partners in Project “Algraal” came together in Castres to mark the official launch of the project. Project “Algraal” was selected as a projet d’excellence by France’s Department of Competitiveness, Industry and Services (DGCIS) in connection with the 16th call for tenders of the Single Inter-Ministerial Fund (FUI).

January 30, 2014
  1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | From 8 Next page Last page Next page

Print Send to a friend Bookmark this page Network

Text size        T- T+